John Salomone, MD

Dr. Wing-Kin Syn specializes in treatment of liver diseases, offering advanced care for patients with alcoholic and non-alcoholic fatty liver disease, liver fibrosis and cirrhosis, chronic liver disease, hepatitis, alcoholic steatohepatitis and non-alcoholic steatohepatitis (NASH). Services include noninvasive assessment of liver disease, liver biopsy and liver elastography. Dr. Syn is interested in clinical trials related to treatment of liver fibrosis and cirrhosis, as well as non-alcoholic fatty liver disease. Additional research interests include identifying risk factors for the progression of liver diseases related to Type 2 diabetes mellitus and methotrexate use, as well as the development of liver cancer.

Dr. Yasar Caliskan is a specialist in transplant nephrology who assesses kidney transplant candidates and cares for patients following transplant surgery. He offers a personalized approach to kidney transplantation, using precision medicine concepts and identifying unique aspects of candidates/recipients through time-honored guidelines, emerging concepts, new medications, and refinements of care. In addition to kidney transplant services, he assesses and treats patients with genetic kidney diseases and proteinuria. Dr. Caliskan's research interests include kidney transplantation with emphasis on cardiovascular, genetic and immunological problems, genetics and immunology of glomerular diseases, and complement associated glomerulonephritis.

Dr. Millie Liao is a radiologist who specializes in diagnostic, interventional, and vascular radiology for patients of all ages. She treats an array of conditions and pathologies, including arterial, venous, and biliary diseases; liver and kidney tumors; fibroids; enlarged prostates; clots; and bleeds. Dr. Liao works to identify appropriate minimally invasive treatment option. She performs various minimally invasive procedures such as thrombectomies for deep vein thrombosis and pulmonary embolisms; recanalization and reconstruction for venous occlusions; endovascular interventions for peripheral arterial disease; uterine artery embolization for fibroids; and ablations, chemoembolization, or radioembolization for liver or kidney tumors.